Artemisinin-based combination therapies (ACT) are currently used as a first-line malaria
therapy in endemic countries worldwide. This systematic review aims at presenting the …

Background Artesunate-sulfadoxine-pyrimethamine (ASSP) is the frontline artemisinin
combination therapy (ACT) in India. Random, irrational, subtherapeutic artemisinin doses …

Artemisinin is the frontline fast-acting anti-malarial against P. falciparum. Emergence and
spread of resistant parasite in eastern-India poses a threat to national malaria control …

The emergence and spread of drug resistance is a problem hindering malaria elimination in
Southeast Asia. In this study, genetic variations in drug resistance markers of Plasmodium …

Background The analysis of single nucleotide polymorphism (SNPs) in drug-resistance
associated genes is a commonly used strategy for the surveillance of anti-malarial drug …

Background. As a result of the spread of parasites resistant to antimalarial drugs, Malaria
treatment guidelines in Cameroon evolved from nonartemisinin monotherapy to artemisinin …

Background Anti-malarial drug resistance is a primary public health problem. Haplotypes of
pfcrt gene have been implicated to be molecular markers of chloroquine (CQ) resistance …

Introduction After being used vigorously for the previous two decades to treat P. falciparum,
chloroquine and sulfadoxine-pyrimethamine were replaced in 2009 with an artemisinin …

One of the major challenges for malaria control and elimination is the spread and
emergence of antimalarial drug resistance. Mutations in Plasmodium falciparum (Pf) and …

Unlike other countries, the chloroquine resistant marker Pfcrt T76 mutant has remained fairly
stable in Ghana several years after official disuse of chloroquine. Certain mutations in …